First Trust Large Cap Growth Fund (FTC)
FTC Clears Chevron-Hess Merger, But Bans Hess CEO From Joining Board
The Federal Trade Commission (FTC) on Monday cleared Chevron's (CVX) $53 billion acquisition of Hess (HES), but barred Hess CEO John Hess from joining Chevron's board, citing concerns about his previous communications with Organization of Petroleum Exporting Countries (OPEC) officials.
FTC clears Chevron-Hess deal, bans John Hess from board
The FTC on Monday alleged that John Hess encouraged senior officials at OPEC to draw down inventories, which would result in higher oil prices. Hess Corp. and Chevron have agreed that they will not appoint Hess to the board in order to facilitate the completion of the merger.
FTC allows Chevron-Hess deal, bars John Hess from board
The U.S. Federal Trade Commission allowed Chevron's $53 billion purchase of Hess Corp on Monday, in an order that barred Hess CEO John Hess from Chevron's board.
FTC Plans to Block Hess CEO from Chevron Board
John Hess would be prevented from Chevron's board as part of deal for antitrust approval of a Hess-Chevron merger.
Promises of 'passive income' on Amazon led to death threats for negative online review, FTC says
The Federal Trade Commission is cracking down on "automation" companies that launch and manage online businesses on behalf of customers in exchange for an upfront investment. The latest case targets Ascend Ecom, which ran an e-commerce money-making scheme, primarily on Amazon.
FTC set to greenlight chevron's $53 billion buy of oil rival Hess, sources say
The U.S. Federal Trade Commission is expected to greenlight U.S. oil producer Chevron's purchase of Hess as soon as this week, two people familiar with the matter said, leaving Exxon Mobil's challenge to the $53 billion deal as its final hurdle.
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice'
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.
FTC Sues CVS, Cigna, UnitedHealth Over Insulin Costs
The US Federal Trade Commission is accusing units of CVS, Cigna, and UnitedHealth of engaging in illegal rebate programs that drove up the price of insulin. Federal Trade Commission Office of Public Affairs Director Douglas Farrar discusses the lawsuit against the pharmacy benefits managers.
FTC sues drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen boost their profits while "artificially" inflating costs for patients. The suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts, and their affiliated group purchasing organizations.
Meta, TikTok and More Sites Engaged in ‘Vast Surveillance,' a New FTC Study Finds
Meta, YouTube and other sites collected more data than most users realized, a new report by the Federal Trade Commission finds.
FTC says Gamestop CEO Cohen to pay nearly $1 million penalty
The U.S. Federal Trade Commission said on Wednesday that Ryan Cohen, managing partner of RC Ventures LLC and Gamestop CEO, would pay a nearly $1 million penalty to settle an antitrust law violation related to his acquisition of Wells Fargo & Co shares.
What's at Stake as FTC's Legal Fight Against Kroger-Albertsons Merger Ends
The Federal Trade Commission's (FTC) legal challenge against the proposed $24.6 billion merger of Kroger (KR) and Albertsons (ACI) is set to end in an Oregon federal court Tuesday, with a judge to rule whether the regulator's antitrust argument is sufficient to halt the combination.
